Big Pharma needs a profit stream it can depend on. Please help.
Guidelines on who is eligible for statins may need to be rewritten after an international trial found benefits in “healthy” adults, experts say.
The study of 17,800 men and women with normal cholesterol levels found rosuvastatin cut deaths from heart attacks and strokes.
Currently statins are offered to people with a moderate to high risk of a cardiovascular “event”.
This study was funded for you by AstraZeneca.
Don’t forget to put your kids on Lipitor - it’s good for their health.
